Advertisement
Advertisement
U.S. markets open in 7 hours 11 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
41.03+0.06 (+0.15%)
At close: 04:00PM EDT
40.66 -0.37 (-0.90%)
After hours: 05:09PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close40.97
Open40.90
Bid0.00 x 1400
Ask0.00 x 2900
Day's Range40.79 - 41.15
52 Week Range34.98 - 47.50
Volume4,860,923
Avg. Volume8,080,508
Market Cap58.739B
Beta (5Y Monthly)0.85
PE Ratio (TTM)70.74
EPS (TTM)0.58
Earnings DateOct 25, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est48.64
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BSX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Boston Scientific Corporation
    Analyst Report: Boston Scientific CorporationBoston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
    Rating
    Fair Value
    Economic Moat
    14 days agoMorningstar
View more
Advertisement
Advertisement